Breaking New Ground: Novel Strategies in Follicular Lymphoma

Ruemu Birhiray, MD of Hematology Oncology of Indiana, Joshua Brody, MD of The Tisch Cancer Institute at Mount Sinai, and Julio Chavez, MD of Moffitt Cancer Center review late-breaking abstracts from the 66th American Society of Hematology Annual Meeting & Exposition, highlighting novel strategies shaping the future of follicular lymphoma treatment. They discuss emerging therapeutic approaches, key clinical trial data, and the potential impact of these advancements on patient care. With insights into next-generation therapies, the discussion explores what’s ahead in the evolving follicular lymphoma landscape.